Translator Disclaimer
Presentation
26 April 2016 Detection of breast positive surgical margins with fluorescence-guided microscopy imaging (Conference Presentation)
Author Affiliations +
Abstract
We present a novel technology based on a high sensitivity/specificity cancer targeting agent and of a novel fluorescence-guided microscopy (FGM) scheme for intraoperative assessment of surgical margins in breast cancer patients. Cancer cells are targeted using an optically silent peptide substrate coupled to a near infrared (NIR) fluorochrome that is cleaved by highly mediated breast cancer enzymes, like urokinase-type plasminogen activator (uPA), to become highly fluorescent when excited by a NIR laser beam. A FGM instrument is used to localize cancer-suspect areas on the lumpectomy specimen and visualize tissue morphology at the sub-cellular scale, such that a trained pathologist can read these images in real-time and confirm or rule-out cancer presence. The proposed technology will enable efficient assessment of surgical specimens during surgery, when it is mostly needed, and therefore help the clinician to determine if additional tissue excision is needed or not. The preliminary testing of this technology on breast surgical specimens will be discussed.
Conference Presentation
© (2016) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Nicusor V. Iftimia, Dorin Preda, Jesung Park, and Mitchell Antalek "Detection of breast positive surgical margins with fluorescence-guided microscopy imaging (Conference Presentation)", Proc. SPIE 9696, Molecular-Guided Surgery: Molecules, Devices, and Applications II, 96960S (26 April 2016); https://doi.org/10.1117/12.2213887
PROCEEDINGS
PRESENTATION


SHARE
Advertisement
Advertisement
Back to Top